![]() Administration of long-acting immune-modifying drugs at any time during the study period (e.g.Inhaled and topical steroids are allowed. ![]() For corticosteroids, this will mean prednisone ≥0.5mg/kg/day, or equivalent. Chronic administration (defined as more than 14 days in total) of immunosuppressants or other immune-modifying drugs during the period starting at birth prior to the first vaccine dose.Medically stable refers to the condition of premature infants who do not require significant medical support or ongoing management for debilitating disease and who have demonstrated a clinical course of sustained recovery by the time they receive the first dose of study vaccine.Medically stable* prematurely born infants, born after a gestation period of 27-36 weeks may be enrolled in the study at the discretion of the investigator. Born to a mother enrolled in study 116945.Healthy subjects as established by medical history and clinical examination before entering into the study.A male or female between, 6 and 14 weeks of age (including 6 weeks and up to and including 14 weeks and 6 days of age) at the time of the first vaccination.Written informed consent obtained from the parent(s)/LAR(s) of the subject prior to performing any study specific procedure.completion of the diary cards, return for follow-up visits). ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |